🔎 Trials Near Me

Почетна › Рак плућа › Охајо

Kliničke studije za Рак плућа u državi Охајо

66 studija za Рак плућа traži učesnike na lokacijama u državi Охајо.

Gradovi u državi Охајо

Zvanični tekst studije (na engleskom)

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Dayton Physician's Network, Dayton
Тражи се учесникФаза 3
Узраст од 18 до 100 · Оба пола · Ажурирано 13. 11. 2026. · NCT05920356

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07063745

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

  • University Hospitals Cleveland Medical Center, Cleveland
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07100080

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon
  • University Hospitals Cleveland Medical Center, Cleveland
  • University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Aultman Health Foundation, Canton
  • Miami Valley Hospital South, Centerville
  • Ohio State University Comprehensive Cancer Center, Columbus
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Cleveland Clinic Akron General, Akron
  • Strecker Cancer Center-Belpre, Belpre
  • Aultman Health Foundation, Canton
  • и још 34
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

  • Dayton VA Medical Center, Dayton
Тражи се учесник
Узраст од 50 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07168993

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • UH Seidman Cancer Center at UH Avon Health Center, Avon
  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • Strecker Cancer Center-Belpre, Belpre
  • и још 22
Тражи се учесникФаза 3
Узраст 70 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06096844

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

  • GSK Investigational Site, Canton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07099898

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Louis Stokes Cleveland VA Medical Center, Cleveland
Тражи се учесникЗдраве особе су добродошле
Узраст од 45 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06995898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  • Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06793215

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Summa Health System - Akron Campus, Akron
  • Cleveland Clinic Akron General, Akron
  • Summa Health System - Barberton Campus, Barberton
  • и још 44
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • UH Seidman Cancer Center at UH Avon Health Center, Avon
  • UHHS-Chagrin Highlands Medical Center, Beachwood
  • Strecker Cancer Center-Belpre, Belpre
  • и још 29
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT04181060

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • The Ohio State University (OSU) Wexner Medical Center, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06400472

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Miami Valley Hospital South, Centerville
  • USO - Oncology Hematology Care, Cincinnati
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06119581

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Gabrail Cancer Center Research, Canton
  • The Christ Hospital Cancer Center, Cincinnati
  • University of Cincinnati Medical Center, Cincinnati
  • и још 5
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06712316

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • Ohio State University Hospitals, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07185997

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

  • Cleveland Clinic Mercy Hospital, Canton
  • University Hospitals Seidman Cancer Center, Cleveland
  • Tri-County Hematology & Oncology Associates, Inc., Massillon
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT05974150

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Case Western Reserve University, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT06287775

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT02984761

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

  • Research Site, Cleveland
Тражи се учесникФаза 2
Узраст од 18 до 95 · Оба пола · Ажурирано 21. 10. 2026. · NCT05061550

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

  • University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT06162221

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

  • Cleveland Clinic - Akron General Hematology & Oncology, Akron
  • Cleveland Clinic Mercy Hospital Cancer Center, Canton
  • The Christ Hospital Cancer Center, Cincinnati
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT06712355

Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)

  • ProMedica Flower Hospital, Sylvania
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07393555

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT05786924

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  • Gabrail Cancer and Research Center, Canton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 10. 2026. · NCT07128199

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Aultman Health Foundation, Canton
  • Miami Valley Hospital South, Centerville
  • Ohio State University Comprehensive Cancer Center, Columbus
  • и још 7
Тражи се учесникФаза 2
18 Minutes · Оба пола · Ажурирано 9. 10. 2026. · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • OhioHealth O'Bleness Hospital, Athens
  • Aultman Health Foundation, Canton
  • Miami Valley Hospital South, Centerville
  • и још 20
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Aultman Hospital, Canton
  • Aultman Medical Group Hematology and Oncology, Canton
  • Oncology Hematology Care Clinical Trials, Cincinnati
  • и још 7
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07222566

Prospective Multiomic Analysis in Small-Cell Lung Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT07795411

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • The Cleveland Clinic Taussig Cancer Center, Cleveland
Тражи се учесникФаза 1/2
Узраст 12 и старији · Оба пола · Ажурирано 2. 10. 2026. · NCT04585750

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

  • University of Cincinnati Cancer Center, Cincinnati
  • The Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT06765109

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

  • GSK Investigational Site, Canton
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT07602855

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • Cleveland Clinic, Cleveland
  • Local Institution - 0102, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 23. 9. 2026. · NCT06618287

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

  • University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07104630

A Study Evaluating a New Radiation Treatment Workflow (NGDS)

  • University Hospital Cleveland Medical Center, Cleveland
Тражи се учесник
Узраст 21 и старији · Оба пола · Ажурирано 17. 9. 2026. · NCT07824583

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04780568

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

  • Case Western Reserve University, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07012031

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06343402

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.